Atlas Trials

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Clinical trial NCT03927027 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03927027
Sponsor
Alliance for Clinical Trials in Oncology
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Start date
2019-07-29
Primary completion
2025-11-26
Enrollment
534

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.